Magellan Health, Inc. (MGLN) to Release Earnings on Tuesday
Magellan Health, Inc. (NASDAQ:MGLN) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, November 7th. Analysts expect Magellan Health to post earnings of $1.40 per share for the quarter.
Magellan Health (NASDAQ:MGLN) last announced its quarterly earnings results on Friday, July 28th. The company reported $0.46 earnings per share for the quarter, missing analysts’ consensus estimates of $0.94 by ($0.48). The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.40 billion. Magellan Health had a return on equity of 8.88% and a net margin of 1.59%. The firm’s revenue for the quarter was up 21.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.58 earnings per share. On average, analysts expect Magellan Health to post $4.69 EPS for the current fiscal year and $5.58 EPS for the next fiscal year.
Shares of Magellan Health, Inc. (MGLN) opened at 84.40 on Tuesday. The stock’s 50 day moving average price is $84.58 and its 200-day moving average price is $76.67. The firm has a market capitalization of $2.00 billion, a PE ratio of 24.03 and a beta of 0.57. Magellan Health, Inc. has a 12 month low of $49.50 and a 12 month high of $88.10.
In other news, CEO Mostafa Kamal sold 2,190 shares of the business’s stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $81.07, for a total value of $177,543.30. Following the transaction, the chief executive officer now directly owns 157 shares of the company’s stock, valued at approximately $12,727.99. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Daniel N. Gregoire sold 2,400 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $83.00, for a total value of $199,200.00. Following the completion of the transaction, the general counsel now directly owns 15,857 shares in the company, valued at $1,316,131. The disclosure for this sale can be found here. Insiders sold a total of 234,536 shares of company stock worth $20,023,252 over the last three months. 3.60% of the stock is owned by company insiders.
A number of equities research analysts have weighed in on the company. KeyCorp raised Magellan Health from a “sector weight” rating to an “overweight” rating and set a $91.00 price objective on the stock in a report on Thursday, July 13th. Zacks Investment Research raised Magellan Health from a “hold” rating to a “buy” rating and set a $90.00 price objective on the stock in a report on Tuesday, July 18th. BidaskClub raised Magellan Health from a “sell” rating to a “hold” rating in a report on Tuesday, August 8th. Jefferies Group LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Magellan Health in a report on Friday, October 13th. Finally, ValuEngine raised Magellan Health from a “hold” rating to a “buy” rating in a report on Friday, September 1st. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $83.00.
About Magellan Health
Magellan Health, Inc is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC).
Receive News & Ratings for Magellan Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magellan Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.